Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib
Pietro Di Marino,1 Gianluca Mannetta,2 Consiglia Carella,3 Antonino Grassadonia,3 Nicola Tinari,3 Clara Natoli,3 Michele De Tursi3 1Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy; 2Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio&rdqu...
Main Authors: | Di Marino P, Mannetta G, Carella C, Grassadonia A, Tinari N, Natoli C, De Tursi M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | International Medical Case Reports Journal |
Subjects: | |
Online Access: | https://www.dovepress.com/alectinib-induced-regression-of-renal-and-hepatic-cysts-caused-by-criz-peer-reviewed-article-IMCRJ |
Similar Items
-
Crizotinib-Associated Renal Cysts: A Case Series
by: Garima Suman, et al.
Published: (2019-07-01) -
Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
by: Daijiro Harada, et al.
Published: (2021-03-01) -
Clinical Efficacy of Crizotinib in Treatment of Patients with Advanced NSCLC
by: Emei GAO, et al.
Published: (2016-03-01) -
Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib
by: Carolina Valeria Mahuad, et al.
Published: (2016-06-01) -
Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China
by: Zihua Zou, et al.
Published: (2022-01-01)